abstract |
The present invention relates to substituted xanthines of the general formulanin which R 1 to R 4 are defined as in claim 1, their tautomers, their stereoisomers, their mixtures, their prodrugs and their salts, which have valuable pharmacological properties, in particular an inhibitory effect on the activity of the enzyme dipeptidyl peptidase-IV (DPP-IV ). |